Antipodes reports 4.8% stake in Brookdale
Antipodes Partners Ltd, an Australian investment adviser, reported beneficial ownership of Brookdale Senior Living Inc. common stock.
Rhea-AI Filing Summary
Antipodes Partners Ltd, an Australian investment adviser, reported beneficial ownership of Brookdale Senior Living Inc. common stock. It holds 11,428,834 shares, representing 4.8% of the outstanding common stock as of the event date of 12/31/2025.
Antipodes has sole power to vote and dispose of all these shares, with no shared voting or dispositive power. The position is certified as being acquired and held in the ordinary course of business and not for the purpose of changing or influencing control of Brookdale. The amended Schedule 13G is signed by Managing Director Andrew Findlay.
Positive
- None.
Negative
- None.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What ownership stake in Brookdale Senior Living Inc. (BKD) does Antipodes Partners report?
What type of investor is Antipodes Partners in relation to Brookdale (BKD)?
Is Antipodes Partners seeking to influence control of Brookdale Senior Living Inc.?
Why is this disclosure for Brookdale (BKD) labeled as Amendment No. 1 to Schedule 13G?
Who signed the Brookdale (BKD) Schedule 13G/A on behalf of Antipodes Partners?
AI-generated analysis. How Rhea-AI works. Not financial advice.